share_log

Clover Health | 10-Q: Q3 2024 Earnings Report

Clover Health | 10-Q: Q3 2024 Earnings Report

Clover Health | 10-Q：2024財年三季報
美股SEC公告 ·  2024/11/08 08:14

Moomoo AI 已提取核心訊息

Clover Health reported strong Q3 2024 financial results with total revenue increasing 8.2% to $331 million, driven by a 7.1% rise in premiums earned to $322.6 million. The company significantly narrowed its net loss to $9.2 million from $41.5 million in Q3 2023, while maintaining a stable medical care ratio of 78.0%.The company demonstrated improved operational efficiency with a 9.2% reduction in salaries and benefits to $55.0 million and a 14.2% decrease in general and administrative expenses to $35.2 million. Other income grew 75.2% to $8.4 million, benefiting from higher interest rates. The Insurance segment served 81,110 Medicare Advantage members across five states.Notable developments include CMS increasing Clover's PPO Medicare Advantage plans rating to 4 Stars for 2025, which will enable a 5% quality bonus increase in benchmark rates for 2026. The company also launched Counterpart Health, a new SaaS solution to extend its AI-powered care management platform to external Medicare Advantage payors and providers.
Clover Health reported strong Q3 2024 financial results with total revenue increasing 8.2% to $331 million, driven by a 7.1% rise in premiums earned to $322.6 million. The company significantly narrowed its net loss to $9.2 million from $41.5 million in Q3 2023, while maintaining a stable medical care ratio of 78.0%.The company demonstrated improved operational efficiency with a 9.2% reduction in salaries and benefits to $55.0 million and a 14.2% decrease in general and administrative expenses to $35.2 million. Other income grew 75.2% to $8.4 million, benefiting from higher interest rates. The Insurance segment served 81,110 Medicare Advantage members across five states.Notable developments include CMS increasing Clover's PPO Medicare Advantage plans rating to 4 Stars for 2025, which will enable a 5% quality bonus increase in benchmark rates for 2026. The company also launched Counterpart Health, a new SaaS solution to extend its AI-powered care management platform to external Medicare Advantage payors and providers.
Clover Health在2024年第三季度報告了強勁的財務業績，總營業收入增長了8.2%，達到了33100萬，主要得益於保費收入增長了7.1%，達到了32260萬。公司顯著縮小了淨虧損，從2023年第三季度的4150萬降至920萬，同時保持了穩定的醫療保健比率爲78.0%。公司展現了提高的運營效率，薪資和福利下降了9.2%，降至5500萬，管理費用下降了14.2%，降至3520萬。其他收入增長了75.2%，達到了840萬，受益於更高的利率期貨。保險部門在五個州服務了81,110名醫療保險優先計劃成員。值得注意的發展包括CMS將Clover的PPO醫療保險優先計劃評級提高到2025年的4星，這將使得2026年的基準費率質量獎金增加5%。公司還推出了Counterpart Health，這是一種新的Saas-雲計算解決方案，旨在將其基於人工智能的護理管理平台擴展到外部醫療保險優先支付者和提供者。
Clover Health在2024年第三季度報告了強勁的財務業績，總營業收入增長了8.2%，達到了33100萬，主要得益於保費收入增長了7.1%，達到了32260萬。公司顯著縮小了淨虧損，從2023年第三季度的4150萬降至920萬，同時保持了穩定的醫療保健比率爲78.0%。公司展現了提高的運營效率，薪資和福利下降了9.2%，降至5500萬，管理費用下降了14.2%，降至3520萬。其他收入增長了75.2%，達到了840萬，受益於更高的利率期貨。保險部門在五個州服務了81,110名醫療保險優先計劃成員。值得注意的發展包括CMS將Clover的PPO醫療保險優先計劃評級提高到2025年的4星，這將使得2026年的基準費率質量獎金增加5%。公司還推出了Counterpart Health，這是一種新的Saas-雲計算解決方案，旨在將其基於人工智能的護理管理平台擴展到外部醫療保險優先支付者和提供者。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Oscar Health
    OSCR
    -- 13.460
    Molina Healthcare
    MOH
    -- 272.280
    哈門那
    HUM
    -- 253.830
    康西哥
    CNC
    -- 56.860
    NeueHealth
    NEUE
    -- 7.330
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    美聯儲暫停降息，你如何調整持倉？
    美聯儲宣布基準利率維持在4.25%—4.50%不變，符合市場預期。你會如何配置資產？ 展开
    FOMC新聞發佈會，2025年1月29日